Format

Send to

Choose Destination
See comment in PubMed Commons below
Cancer Treat Rev. 2010 Apr;36(2):151-6. doi: 10.1016/j.ctrv.2009.11.006. Epub 2009 Dec 22.

Forkhead box M1 transcription factor: a novel target for cancer therapy.

Author information

1
Department of Pathology, Karmanos Cancer Institute, Wayne State University, 540 E. Canfield, Detroit, MI 48201, USA.

Abstract

FoxM1 signaling has been reported to be associated with carcinogenesis. Therefore, the FoxM1 may represent a novel therapeutic target, and thus the development of agents that will target FoxM1 is likely to have significant therapeutic impact on human cancer. This review describes the mechanisms of signal transduction associated with FoxM1 and provides emerging evidence in support of its role in the carcinogenesis. Further, we summarize data on several FoxM1 inhibitors especially "chemopreventive agents" and these agents could be useful for targeted inactivation of FoxM1, which indeed could become a novel approach for the prevention and/or treatment of human cancer.

KEYWORDS:

FoxM1; cancer; cell signaling pathway; chemopreventive agents

PMID:
20022709
PMCID:
PMC2838950
DOI:
10.1016/j.ctrv.2009.11.006
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center